https://optionstrading.zone/market-insights/kb-home-q2-2026-results-kbh-after-revenue-fell-27-eps-printed-0-43-and-guidance-pointed-to-seque/ OptionsTrading.Zone en 2026-06-23T21:22:46Z KB Home Q2 earnings: what KBH's muted reaction says about housing premium https://optionstrading.zone/market-insights/carnival-q2-2026-earnings-ccl-implied-move-vs-realized-move-after-record-revenue-usd-9-billion-d/ OptionsTrading.Zone en 2026-06-23T15:04:14Z Carnival Q2 earnings: what CCL's post-report drop says about the premium traders paid https://optionstrading.zone/market-insights/occ-updates-two-harbors-cash-merger-mechanics-what-12-00-cash-settlement-and-accelerated-expirat/ OptionsTrading.Zone en 2026-06-23T09:03:05Z OCC updates Two Harbors merger memo: what $12.00 cash settlement could mean for TWO options https://optionstrading.zone/market-insights/robinhood-s-june-trading-color-shows-options-pace-staying-elevated-as-event-contracts-scale/ OptionsTrading.Zone en 2026-06-23T01:12:23Z Robinhood's June trading color: options stay hot while event contracts scale https://optionstrading.zone/market-insights/spacex-launches-first-bond-offering-after-its-ipo-what-a-20-billion-debt-turn-could-change-for-s/ OptionsTrading.Zone en 2026-06-23T01:07:26Z SpaceX's first post-IPO bond deal: what new debt changes for SPCX options https://optionstrading.zone/market-insights/abbvie-signs-a-definitive-10-9-billion-cash-deal-for-apogee-therapeutics-what-changes-for-apge-o/ OptionsTrading.Zone en 2026-06-22T14:57:05Z AbbVie-Apogee signed cash deal: what APGE options traders should watch now https://optionstrading.zone/market-insights/crh-signs-an-8-5-billion-all-cash-arcosa-deal-what-aca-options-traders-should-watch-now/ OptionsTrading.Zone en 2026-06-22T12:58:36Z CRH-Arcosa cash merger: what ACA options traders should watch after the signed $150 deal https://optionstrading.zone/market-insights/abbvie-nears-a-10-9-billion-cash-deal-for-apogee-therapeutics-what-apge-options-traders-should-w/ OptionsTrading.Zone en 2026-06-22T10:54:27Z AbbVie-Apogee cash-deal talks: what APGE options traders should watch now